Essential role for oncogenic Ras in tumour maintenance

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Tumorigenesis involves genetic alterations affecting oncogenes and tumor suppressors.
• Established tumors rely on complex host-tumor interactions for maintenance, including angiogenesis and immune evasion.
• The relevance of initial cancer-promoting mutations during tumor maintenance remains unclear.

Purpose of the Study:

• To investigate the role of H-RasV12G in melanoma genesis and maintenance.
• To determine if H-RasV12G is essential for sustaining established tumors.
• To explore the mechanisms by which activated Ras maintains tumors in vivo.

Main Methods:

• Utilized a doxycycline-inducible H-RasV12G mouse melanoma model lacking the INK4a tumor suppressor.
• Administered doxycycline to induce H-RasV12G expression and subsequently withdrew it to observe effects.
• Analyzed tumor regression, apoptosis, and vascular endothelial growth factor (VEGF) regulation in vitro and in vivo.

Main Results:

• Down-regulation of H-RasV12G upon doxycycline withdrawal caused significant clinical and histological regression of melanomas.
• Tumor regression was associated with apoptosis in both tumor and endothelial cells.
• Activated Ras's tumor-maintaining functions extend beyond VEGF regulation, as demonstrated by the failure of VEGF to sustain tumor viability.

Conclusions:

• H-RasV12G is essential for both the initiation (genesis) and continued growth (maintenance) of solid tumors, specifically melanoma.
• Targeting H-RasV12G represents a potential therapeutic strategy for established melanomas.
• The study provides critical genetic evidence for the dual role of oncogenes in tumor development and progression.